Stock 600267 ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Zhejiang Hisun Pharmaceutical Co., Ltd.

Equities

600267

CNE0000013Z2

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
8.16 CNY +3.29% Intraday chart for Zhejiang Hisun Pharmaceutical Co., Ltd. +9.68% -12.82%
Apr. 29 Zhejiang Hisun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 29 Zhejiang Hisun Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Zhejiang Hisun Pharmaceutical Co., Ltd. is a China-based company, principally engaged in the research and development, manufacture and distribution of specialty bulk pharmaceutical chemicals and preparation products. The Company's bulk pharmaceutical chemicals mainly include antineoplastic drugs, cardiovascular drugs, anti-infection drugs, endocrine control drugs, anthelmintic, as well as animal remedies, among others. The Company is also engaged in the sales of drugs manufactured by other companies. The Company distributes its products in domestic markets and to overseas markets.

Number of employees: 8,325

Sales per Business

CNY in Million2021Weight2022Weight Delta
Pharmaceutical Distribution
33.1 %
- - 3,989 33.1 % -
Anti-Infective Drugs
18.2 %
2,747 22.6 % 2,192 18.2 % -20.21%
Cardiovascular Drugs
14.4 %
1,368 11.3 % 1,734 14.4 % +26.76%
Anti-tumor Drugs
8.1 %
841 6.9 % 972 8.1 % +15.50%
Import of Finished Drugs and Promotion of Imported Preparations
7.7 %
- - 925 7.7 % -
Antiparasitic & Veterinary Drugs
7.6 %
892 7.3 % 916 7.6 % +2.77%
Other Drugs
4.6 %
694 5.7 % 558 4.6 % -19.60%
Endocrine Drugs
2.9 %
432 3.6 % 350 2.9 % -18.91%
Other Business
2.7 %
234 1.9 % 328 2.7 % +40.19%
CMO/CDMO/CRO
0.5 %
- - 65 0.5 % -
Other
0.1 %
12 0.1 % 8 0.1 % -30.59%

Sales per region

CNY in Million2021Weight2022Weight Delta
China
93.2 %
10,901 91.6 % 10,910 93.2 % +0.08%
Foreign
6.8 %
1,001 8.4 % 798 6.8 % -20.26%

Managers

Managers TitleAgeSince
Zhi Qing Yang CEO
 Chief Executive Officer - 23-08-30
Jia Qiu Du CHM
 Chairman 50 19-05-12
Wei Hong Xiao PSD
 President 56 23-10-10
Shun Bing Yu CHM
 Chairman 61 -
Xi Fei Shen SEC
 Corporate Secretary 52 17-10-16

Members of the board

Members of the board TitleAgeSince
Shun Bing Yu CHM
 Chairman 61 -
Jia Yi Zhao BRD
 Director/Board Member 64 19-05-12
Li Rong Yang BRD
 Director/Board Member 62 19-05-12
Rong Fu Fei BRD
 Director/Board Member 39 18-01-18
Jia Qiu Du CHM
 Chairman 50 19-05-12
Hua Li Zhou BRD
 Director/Board Member 47 22-04-18
Bo Chao Zheng BRD
 Director/Board Member 45 18-08-14
Junli Jin BRD
 Director/Board Member 44 19-05-12
Hua Ping Zheng BRD
 Director/Board Member 37 22-04-18
Xing Hu Shen BRD
 Director/Board Member 53 23-08-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,263,530,275 680,523,114 ( 53.86 %) 55,656,559 ( 4.405 %) 53.86 %

Shareholders

NameEquities%Valuation
District of Jiaojiang
29.37 %
320,783,590 29.37 % 341 M ¥
Zhejiang State-Owned Asset Sup. & Admin. Commission
6.653 %
72,673,907 6.653 % 77 M ¥
Yung Kong Li
5.355 %
58,498,791 5.355 % 62 M ¥
Bosera Asset Management Co., Ltd.
1.887 %
20,613,900 1.887 % 22 M ¥
China Southern Asset Management Co., Ltd.
0.9434 %
10,305,808 0.9434 % 11 M ¥
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.
0.9329 %
10,191,200 0.9329 % 11 M ¥
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)
0.8144 %
8,896,057 0.8144 % 9 M ¥
Yinhua Fund Management Co., Ltd.
0.5073 %
5,541,362 0.5073 % 6 M ¥
Yin Sheng Peng
0.4548 %
4,968,108 0.4548 % 5 M ¥
Bing Ji Zhou
0.3783 %
4,131,900 0.3783 % 4 M ¥
NameEquities%Valuation
District of Jiaojiang
77.87 %
59,931,506 77.87 % 64 M ¥
Hong Shun Jin
0.2157 %
166,000 0.2157 % 176 624 ¥

Holdings

NameEquities%Valuation
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.
0.93%
 10,191,200 0.93% 10,843,437 $

Company contact information

Zhejiang Hisun Pharmaceutical Co., Ltd.

No. 46 Waisha Road Jiaojiang District

318000, Taizhou

+86 576 8882 7890

http://www.hisunpharm.com
address Zhejiang Hisun Pharmaceutical Co., Ltd.(600267)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Zhejiang Hisun Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
8.16 CNY
Average target price
7.4 CNY
Spread / Average Target
-9.31%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. Stock Zhejiang Hisun Pharmaceutical Co., Ltd.
-12.82% 1.34B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+33.25% 704B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+28.59% 577B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.55% 348B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.16% 327B
ABBVIE INC. Stock AbbVie Inc.
+4.36% 288B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.81% 234B
NOVARTIS AG Stock Novartis AG
+4.93% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-9.78% 194B
AMGEN INC. Stock Amgen Inc.
-3.69% 147B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600267 Stock
  4. Company Zhejiang Hisun Pharmaceutical Co., Ltd.